Results 1-101 of 101 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12021Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan – a population-based studyHuang H.-H.; Hsiao F.-Y.; Chen H.-M.; Wang C.-Y.; BOR-SHENG KO British Journal of Haematology1
22020A Knowledge-Reserved Distillation with Complementary Transfer for Automated FC-based Classification Across Hematological MalignanciesLi J.-L.; Chang T.-Y.; Wang Y.-F.; BOR-SHENG KO ; Tang J.-L.; Lee C.-C.Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS0
32020Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training programTseng F.-Y.; Lin L.-C.; BOR-SHENG KO ; Chu T.-S.; Tsai S.-L.; Sheng W.-H.; Yen C.-J.; Chang C.-H.; Wu C.-H.; Shih S.-R.; Chiu W.-Y.; Pan S.-C.; Chen W.-P.; Chang P.-Y.Journal of the Formosan Medical Association00
42020Expression of Nik-related kinase in smooth muscle cells attenuates vascular inflammation and intimal hyperplasiaLu Y.-J.; Jan Y.-J.; BOR-SHENG KO ; Liang S.-M.; Chen L.; Wu C.-C.; Chin C.-H.; Kuo C.-C.; Yet S.-F.; Liou J.-Y.Aging34
52020Frontline treatments in extremely elderly patients with diffuse large B-cell lymphoma: A population-based study in Taiwan, 2010-2015Huang H.-H.; BOR-SHENG KO ; Chen H.-M.; Chen L.-J.; Wang C.-Y.; Hsiao F.-Y.Immunity and Ageing2
62020Economic burden of cancers in Taiwan: A direct and indirect cost estimate for 2007-2017Huang S.-Y.; Chen H.-M.; Liao K.-H.; BOR-SHENG KO ; Hsiao F.-Y.BMJ Open00
72020Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series AnalysisLiao K.-H.; BOR-SHENG KO ; Chen L.-K.; Hsiao F.-Y.Clinical and Translational Science00
82020Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in TaiwanWang Y.-H.; Yu S.-C.; BOR-SHENG KO ; Yang Y.-T.; Yao M.; Tang J.-L.; Huang T.-C.International Journal of Hematology01
92019Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in TaiwanBOR-SHENG KO ; Chang M.-C.; Chiou T.-J.; Chang T.-K.; Chen Y.-C.; Lin S.-F.; Chang C.-S.; Lu Y.-C.; Yeh S.-P.; Chen T.-Y.; Hwang W.-S.Hematology (United Kingdom)32
102019Cordycepin suppresses endothelial cell proliferation, migration, angiogenesis, and tumor growth by regulating focal Adhesion Kinase and p53Lin Y.-T.; Liang S.-M.; Wu Y.-J.; Wu Y.-J.; Lu Y.-J.; Jan Y.-J.; BOR-SHENG KO ; Chuang Y.-J.; Shyue S.-K.; Kuo C.-C.; Liou J.-Y.Cancers6
112019A BLSTM with Attention Network for Predicting Acute Myeloid Leukemia Patient's Prognosis using Comprehensive Clinical ParametersLu C.-C.; Li J.-L.; Wang Y.-F.; BOR-SHENG KO ; Tang J.-L.; Lee C.-C.Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS20
122019Learning a Cytometric Deep Phenotype Embedding for Automatic Hematological Malignancies ClassificationLi J.-L.; Wang Y.-F.; BOR-SHENG KO ; Li C.-C.; Tang J.-L.; Lee C.-C.Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS20
132019ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinomaWu Y.-J.; BOR-SHENG KO ; Liang S.-M.; Lu Y.-J.; Jan Y.-J.; Jiang S.-S.; Shyue S.-K.; Chen L.; Liou J.-Y.Cell Death and Disease46
142019Women with diffuse large B cell lymphoma benefit more from rituximab-containing chemotherapyHuang H.-H.; Hsiao F.-Y.; Chen L.-J.; Chen H.-M.; BOR-SHENG KO Journal of Women's Health12
152019Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndromeHuang H.-H.; Chen F.-Y.; Chou W.-C.; Hou H.-A.; BOR-SHENG KO ; Lin C.-T.; Tang J.-L.; Li C.-C.; Yao M.; Tsay W.; Hsu S.-C.; Wu S.-J.; Chen C.-Y.; Huang S.-Y.; Tseng M.-H.; Tien H.-F.; Chen R.-H.BMC Cancer1518
162019Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort studyLiu J.-H.; Liao X.-W.; Chen C.-H.; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; Chou W.-C.; Hou H.-A.; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; BOR-SHENG KO British Journal of Haematology22
172018Rituximab maintenance improves overall survival in follicular lymphoma: A retrospective nationwide real-world analysis from Taiwan Cancer Registry DatabaseHuang H.-H.; Wen Y.-C.; Chen H.-M.; Hsiao F.-Y.; BOR-SHENG KO Cancer Medicine44
182018Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndromeLin M.-E.; Hou H.-A.; Tsai C.-H.; Wu S.-J.; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Chou W.-C.; Chen C.-Y.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Lin C.-T.; Tien H.-F.Clinical Epigenetics1515
1920182016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in TaiwanKung H.-C.; Huang P.-Y.; Chen W.-T.; BOR-SHENG KO ; Chen Y.-C.; Chang S.-C.; Chuang Y.-C.; The Infectious Diseases Society of Taiwan, Medical Foundation in Memory of Dr. Deh-Lin Cheng, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research; Education, CY Lee's Research Foundation for Pediatric Infectious Diseases; VaccinesJournal of Microbiology, Immunology and Infection2118
202018Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patientsTien F.-M.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F.European Journal of Haematology1311
2120182016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in TaiwanBOR-SHENG KO ; Chen W.-T.; Kung H.-C.; Wu U.-I.; Tang J.-L.; Yao M.; Chen Y.-C.; Tien H.-F.; Chang S.-C.; Chuang Y.-C.; Lin D.-T.; The Infectious Diseases Society of Taiwan, The Hematology Society of Taiwan, The Taiwan Society of Blood; Marrow Transplantation, Medical Foundation in Memory of Dr Deh-Lin Cheng, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research; Education, CY Lee's Research Foundation for Pediatric Infectious Diseases; VaccinesJournal of Microbiology, Immunology and Infection98
222018Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndromeBOR-SHENG KO ; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; Hou H.-A.; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; Chou W.-C.; Tien H.-F.; Lee C.-C.; Tang J.-L.EBioMedicine2018
232018GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemiaTien F.-M.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; BOR-SHENG KO ; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F.Blood Cancer Journal1817
242018Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPATien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F.Haematologica117
252018Subtype-specific epidemiology of lymphoid malignancies in Taiwan compared to Japan and the United States, 2002-2012BOR-SHENG KO ; Chen L.-J.; Huang H.-H.; Wen Y.-C.; Liao C.-Y.; Chen H.-M.; Hsiao F.-Y.Cancer Medicine55
262018Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II TrialLin C.-T.; Hsueh P.-R.; Wu S.-J.; Yao M.; BOR-SHENG KO ; Li C.-C.; Hsu C.-A.; Tang J.-L.; Tien H.-F.Biology of Blood and Marrow Transplantation22
272018Prognostic significance of 14-3-3ε, aldo-keto reductase family 1 B10 and metallothionein-1 in hepatocellular carcinomaWu C.-Y.; Jan Y.-J.; BOR-SHENG KO ; Wu Y.-J.; Wu Y.-J.; Liou J.-Y.Anticancer Research33
282017Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute PhaseYu S.-C.; Huang H.-H.; Li C.-C.; Tang J.-L.; Lee Y.-H.; Mao T.-L.; Kuo K.-T.; Lin C.-T.; Liu J.-H.; BOR-SHENG KO ; Yao M.Biology of Blood and Marrow Transplantation11
292017Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activityLiang S.-M.; Lu Y.-J.; BOR-SHENG KO ; Jan Y.-J.; Shyue S.-K.; Yet S.-F.; Liou J.-Y.Scientific Reports1311
302017An efficient transfection method for differentiation and cell proliferation of mouse embryonic stem cellsLiou J.-Y.; BOR-SHENG KO ; Chang T.-C.Methods in Molecular Biology10
312017Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemiaTsai C.-H.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Li C.-C.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Chen C.-Y.; Tsay W.; Chuang E.Y.; Chou W.-C.; Tien H.-F.Blood Cancer Journal2022
322016Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaTsai C.-H.; Hou H.-A.; Tang J.-L.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tien H.-F.Leukemia7367
332016Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)Yao C.-Y.; Hou H.-A.; Lin T.-Y.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Kuo Y.-Y.; Wu S.-J.; Liao X.-W.; Lin C.-T.; BOR-SHENG KO ; Chen C.-Y.; Hsu S.-C.; Li C.-C.; Huang S.-Y.; Yao M.; Tang J.-L.; Tsay W.; Liu C.-Y.; Tien H.-F.Oncotarget109
342016Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemiaHou H.-A.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Tsai C.-H.; Lin C.-C.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.Y.; BOR-SHENG KO ; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Tien H.-F.Oncotarget5448
352016Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiationChiang Y.; Tsai C.-H.; Kuo S.-H.; Liu C.-Y.; Yao M.; Li C.-C.; Huang S.-Y.; BOR-SHENG KO ; Lin C.-T.; Hou H.-A.; Chou W.-C.; Liu J.-H.; Lin C.-C.; Wu S.-J.; Hsu S.-C.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Chou H.-T.; Lu M.-Y.; Yang Y.-L.; Chang H.-H.; Liu M.-C.; Liao X.-W.; Wu J.-K.; Chou S.-C.; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; Tang J.-L.; Chen Y.-H.Scientific Reports107
362016Breakthrough invasive fungal infection under the use of posaconazole and voriconazoleLee S.-H.; Sun H.-Y.; BOR-SHENG KO ; Chang S.-C.Journal of the Formosan Medical Association11
372016Paracrine regulation of matrix metalloproteinases contributes to cancer cell invasion by hepatocellular carcinoma-secreted 14-3-3sLiu C.-C.; Chang T.-C.; Lin Y.-T.; Yu Y.-L.; BOR-SHENG KO ; Sung L.-Y.; Liou J.-Y.Oncotarget1011
382015Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adultsCheng C.-L.; Li C.-C.; Hou H.-A.; Fang W.-Q.; Chang C.-H.; Lin C.-T.; Tang J.-L.; Chou W.-C.; Chen C.-Y.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Wu S.-J.; Tsay W.; Tien H.-F.BMC Cancer2524
392015GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolutionHou H.-A.; Lin Y.-C.; Kuo Y.-Y.; Chou W.-C.; Lin C.-C.; Liu C.-Y.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.Annals of Hematology1514
402015Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and their derivativesChen H.-F.; Yu C.-Y.; Chen M.-J.; Chou S.-H.; Chiang M.-S.; Chou W.-H.; BOR-SHENG KO ; Huang H.-P.; Kuo H.-C.; Ho H.-N.Cell Transplantation2018
412015Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective studyHuang S.-Y.; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Hou H.-A.; Chou W.-C.; Chou S.-C.; Hsu S.-C.; BOR-SHENG KO ; Lu H.-Y.; Tsay W.; Tien H.-F.PLoS ONE96
422015Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3∈ and their prognostic impact of hepatocellular carcinomaLiu T.-A.; Jan Y.-J.; BOR-SHENG KO ; Wu Y.-J.; Lu Y.-J.; Liang S.-M.; Liu C.-C.; Chen S.-C.; Wang J.; Shyue S.-K.; Liou J.-Y.Oncotarget1011
432015TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolutionHou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.Blood Cancer Journal7678
442015Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemiaChen Y.-K.; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.PLoS ONE63
452015Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cellsCheng Y.-T.; Yeih D.-F.; Liang S.-M.; Chien C.-Y.; Yu Y.-L.; BOR-SHENG KO ; Jan Y.-J.; Kuo C.-C.; Sung L.-Y.; Shyue S.-K.; Chen M.-F.; Yet S.-F.; Wu K.K.; Liou J.-Y.International Journal of Cardiology109
462015Involvement of 14-3-3 proteins in regulating tumor progression of hepatocellular carcinomaWu Y.-J.; Jan Y.-J.; BOR-SHENG KO ; Liang S.-M.; Liou J.-Y.Cancers31
472015High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in TaiwanTang J.-L.; Kung H.-C.; Lei W.-C.; Yao M.; Wu U.-I.; Hsu S.-C.; Lin C.-T.; Li C.-C.; Wu S.-J.; Hou H.-A.; Chou W.-C.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Chen Y.-C.; Chang S.-C.; BOR-SHENG KO ; Tien H.-F.PLoS ONE3836
482014A call for action to improve access to care and treatment for patients with rare diseases in the Asia-Pacific regionSoon S.-S.; Lopes G.; Lim H.-Y.; Wong-Rieger D.; Bahri S.; Hickinbotham L.; Jha A.; BOR-SHENG KO ; MacDonell D.; Pwu J.R.-F.; Shih R.; Sirachainan E.; Suh D.-C.; Wale J.; Zhang X.; Wee H.-L.Orphanet Journal of Rare Diseases44
492014IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolutionLin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.American Journal of Hematology6562
502014Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progressionHou H.-A.; Kuo Y.-Y.; Tang J.-L.; Chou W.-C.; Yao M.; Lai Y.-J.; Lin C.-C.; Chen C.-Y.; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Huang S.-Y.; BOR-SHENG KO ; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.American Journal of Hematology4947
512014Cordycepin suppresses integrin/FAK signaling and epithelial-mesenchymal transition in hepatocellular CarcinomaYao W.-L.; BOR-SHENG KO ; Liu T.-A.; Liang S.-M.; Liu C.-C.; Lu Y.-J.; Tzean S.-S.; Shen T.-L.; Liou J.-Y.Anti-Cancer Agents in Medicinal Chemistry3228
522014Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantationsChou S.-C.; Tang J.-L.; Hou H.-A.; Chou W.-C.; Hu F.-C.; Chen C.-Y.; Yao M.; BOR-SHENG KO ; Huang S.-Y.; Tsay W.; Chen Y.-C.; Tien H.-F.Leukemia Research1716
53201414-3-3σ induces heat shock protein 70 expression in hepatocellular carcinomaLiu C.-C.; Jan Y.-J.; BOR-SHENG KO ; Wu Y.-M.; Liang S.-M.; Chen S.-C.; Lee Y.-M.; Liu T.-A.; Chang T.-C.; Wang J.; Shyue S.-K.; Sung L.-Y.; Liou J.-Y.BMC Cancer2422
542014SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolutionLin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Wu S.-J.; Liu C.-Y.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Hsu S.-C.; BOR-SHENG KO ; Tsay W.; Chen Y.-C.; Tien H.-F.American Journal of Hematology2622
552014Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statementBOR-SHENG KO ; Chang C.-S.; Chang M.-C.; Chen T.Y.; Chiou T.-J.; Chiu C.-F.; Huang W.-L.; Kao W.-Y.; Lan Y.-J.; Lin S.-F.; Tan T.-D.; Tang J.-L.; Tzeng C.-H.; Wang P.-N.; Yet S.-P.; Tien H.-F.International Journal of Hematology64
562014Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemiaHou H.-A.; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; Tang J.-L.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.Leukemia6363
572014IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patientsYang Y.-T.; Hou H.-A.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Kuo Y.-Y.; Huang S.-Y.; BOR-SHENG KO ; Chen C.-Y.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.American Journal of Hematology1614
582013Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence - Clinical implication and comparison between the West and the EastWu S.-J.; Lin C.-T.; Huang S.-Y.; Lee F.-Y.; Liu M.-C.; Hou H.-A.; Chen C.-Y.; BOR-SHENG KO ; Chou W.-C.; Yao M.; Tang J.-L.; Tsay W.; Tien H.-F.Annals of Hematology119
592013Upregulation of Focal adhesion kinase by 14-3-3ε via NFκB activation in Hepatocellular CarcinomaBOR-SHENG KO ; Jan Y.-J.; Chang T.-C.; Liang S.-M.; Chen S.-C.; Liu T.-A.; Wu Y.-M.; Wang J.; Liou J.-Y.Anti-Cancer Agents in Medicinal Chemistry2522
60201314-3-3ε Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular CarcinomaLiu T.-A.; Jan Y.-J.; BOR-SHENG KO ; Liang S.-M.; Chen S.-C.; Wang J.; Hsu C.; Wu Y.-M.; Liou J.-Y.PLoS ONE5140
612013Expression of partitioning defective 3 (Par-3) for predicting extrahepatic metastasis and survival with hepatocellular carcinomaJan Y.-J.; BOR-SHENG KO ; Liu T.-A.; Wu Y.-M.; Liang S.-M.; Chen S.-C.; Wang J.; Liou J.-Y.International Journal of Molecular Sciences1817
622013Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progressionWu S.-J.; Tang J.-L.; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Tsay W.; Tien H.-F.American Journal of Hematology3934
632013Cordycepin Regulates GSK-3β/β-Catenin Signaling in Human Leukemia CellsBOR-SHENG KO ; Lu Y.-J.; Yao W.-L.; Liu T.-A.; Tzean S.-S.; Shen T.-L.; Liou J.-Y.PLoS ONE2527
642013Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemiaCheng C.-L.; Hou H.-A.; Lee M.-C.; Liu C.-Y.; Jhuang J.-Y.; Lai Y.-J.; Lin C.-W.; Chen H.-Y.; Liu F.-T.; Chou W.-C.; Chen C.-Y.; Tang J.-L.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Wu S.-J.; Tsay W.; Tien H.-F.Blood4432
652013Roles of cancer registries in enhancing oncology drug access in the asia-pacific regionSoon S.-S.; Lim H.-Y.; Lopes G.; Ahn J.; Hu M.; Ibrahim H.M.; Jha A.; BOR-SHENG KO ; Lee P.W.; MacDonell D.; Sirachainan E.; Wee H.-L.Asian Pacific Journal of Cancer Prevention31
662012DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implicationsHou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Chou W.-C.; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.Blood171161
67201214-3-3σ regulates β-catenin-mediated mouse embryonic stem cell proliferation by sequestering GSK-3βChang T.-C.; Liu C.-C.; Hsing E.-W.; Liang S.-M.; Chi Y.-H.; Sung L.-Y.; Lin S.-P.; Shen T.-L.; BOR-SHENG KO ; Yen B.L.; Yet S.-F.; Wu K.K.; Liou J.-Y.PLoS ONE1820
682012Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remissionChou W.-C.; Peng K.-Y.; Lei W.-C.; BOR-SHENG KO ; Tsay W.; Kuo C.-H.; Tien H.-F.Leukemia1615
692012The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolutionWu S.-J.; Kuo Y.-Y.; Hou H.-A.; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen C.-Y.; Chou W.-C.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Tang J.-L.; Tsay W.; Tien H.-F.Blood10490
702012A Knock-In Npm1 Mutation in Mice Results in Myeloproliferation and Implies a Perturbation in Hematopoietic MicroenvironmentChou S.-H.; BOR-SHENG KO ; Chiou J.-S.; Hsu Y.-C.; Tsai M.-H.; Chiu Y.-C.; Yu I.-S.; Lin S.-W.; Hou H.-A.; Kuo Y.-Y.; Lin H.-M.; Wu M.-F.; Chou W.-C.; Tien H.-F.PLoS ONE1614
712011Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinomaBOR-SHENG KO ; Chang T.-C.; Hsu C.; Chen Y.-C.; Shen T.-L.; Chen S.-C.; Wang J.; Wu K.K.; Jan Y.-J.; Liou J.-Y.Histopathology4542
722011The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemiaChou W.-C.; Lei W.-C.; BOR-SHENG KO ; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F.Leukemia103
732011TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogeneticsChou W.-C.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; BOR-SHENG KO ; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo Y.-Y.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F.Blood209195
742011Involvement of 14-3-3γ overexpression in extrahepatic metastasis of hepatocellular carcinomaBOR-SHENG KO ; Lai I.-R.; Chang T.-C.; Liu T.-A.; Chen S.-C.; Wang J.; Jan Y.-J.; Liou J.-Y.Human Pathology2823
752011Cardiac involvement of natural killer/T-cell lymphoma presenting with electrical storm after cardioverter-defibrillator implantationHuang S.-H.; Hsieh S.-C.; BOR-SHENG KO ; Liu Y.-B.Journal of Clinical Oncology24
762011Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinomaLiu T.-A.; Jan Y.-J.; BOR-SHENG KO ; Chen S.-C.; Liang S.-M.; Hung Y.-L.; Hsu C.; Shen T.-L.; Lee Y.-M.; Chen P.-F.; Wang J.; Shyue S.-K.; Liou J.-Y.American Journal of Pathology3432
772011Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: A case report and literature reviewLiu J.-Y.; Chen W.-T.; BOR-SHENG KO ; Yao M.; Hsueh P.-R.; Hsiao C.-H.; Kuo Y.-M.; Chen Y.-C.Medical Mycology2730
782011High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromesCheng C.-L.; Hou H.-A.; Jhuang J.-Y.; Lin C.-W.; Chen C.-Y.; Tang J.-L.; Chou W.-C.; Tseng M.-H.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.British Journal of Cancer1817
792010Focal Adhesion Kinase as a Therapeutic Target of BortezomibBOR-SHENG KO ; Chang T.-C.; Liou J.-Y.Anti-Cancer Agents in Medicinal Chemistry5
802010Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cells.Chang M.; Hsiao J.K.; Yao M.; Chien L.Y.; Hsu S.C.; BOR-SHENG KO ; Chen S.T.; Liu H.M.; Chen Y.C.; Yang C.S.; Huang D.M.Nanotechnology1514
812010Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa BBOR-SHENG KO ; Chang T.-C.; Chen C.-H.; Liu C.-C.; Kuo C.-C.; Hsu C.; Shen Y.-C.; Shen T.-L.; Golubovskaya V.M.; Chang C.-C.; Shyue S.-K.; Liou J.-Y.Life Sciences3836
822010Rho kinases regulate the renewal and neural differentiation of embryonic stem cells in a cell plating density-dependent mannerChang T.-C.; Chen Y.-C.; Yang M.-H.; Chen C.-H.; Hsing E.-W.; BOR-SHENG KO ; Liou J.-Y.; Wu K.K.PLoS ONE2826
832010WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring systemHou H.-A.; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.Blood116115
842010Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutationsChou W.-C.; Huang H.-H.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; BOR-SHENG KO ; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F.Blood149136
852010An efficient transfection method for mouse embryonic stem cellsLiou J.-Y.; BOR-SHENG KO ; Chang T.-C.Methods in Molecular Biology90
862010Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutationChou W.-C.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; BOR-SHENG KO ; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F.Blood168166
872010The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cellsChen Y.-C.; Hsiao J.-K.; Liu H.-M.; Lai I.-Y.; Yao M.; Hsu S.-C.; BOR-SHENG KO ; Chen Y.-C.; Yang C.-S.; Huang D.-M.Toxicology and Applied Pharmacology132137
882009Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinomaJan Y.-J.; BOR-SHENG KO ; Hsu C.; Chang T.-C.; Chen S.-C.; Wang J.; Liou J.-Y.Human Pathology2525
892009AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterationsTang J.-L.; Hou H.-A.; Chen C.-Y.; Liu C.-Y.; Chou W.-C.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; BOR-SHENG KO ; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Lin L.-I.; Tien H.-F.Blood239227
902009The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticlesHuang D.-M.; Hsiao J.-K.; Chen Y.-C.; Chien L.-Y.; Yao M.; Chen Y.-K.; BOR-SHENG KO ; Hsu S.-C.; Tai L.-A.; Cheng H.-Y.; Wang S.-W.; Yang C.-S.; Chen Y.-C.Biomaterials228228
912009An efficient transfection method for mouse embryonic stem cellsBOR-SHENG KO ; Chang T.C.; Shyue S.K.; Chen Y.C.; Liou J.Y.Gene Therapy1917
922009Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patientsChou W.-C.; Chen C.-Y.; Hou H.-A.; Lin L.-I.; Tang J.-L.; Yao M.; Tsay W.; BOR-SHENG KO ; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F.Leukemia4543
932008Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studiesHuang T.-C.; BOR-SHENG KO ; Tang J.-L.; Hsu C.; Chen C.-Y.; Tsay W.; Huang S.-Y.; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F.Leukemia3837
942007Cyclooxygenase-2-derived prostaglandin E2 protects mouse embryonic stem cells from apoptosisLiou J.-Y.; Ellent D.P.; Lee S.; Goldsby J.; BOR-SHENG KO ; Matijevic N.; Huang J.-C.; Wu K.K.Stem Cells5751
952006Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [1]Chen C.-Y.; Lin L.-I.; Tang J.-L.; Tsay W.; Chang H.-H.; Yeh Y.-C.; Huang C.-F.; Chiou R.-J.; Yao M.; BOR-SHENG KO ; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Tien H.-F.Leukemia3435
962005Isolation of multipotent cells from human term placentaYen B.L.; Huang H.-I.; Chien C.-C.; Jui H.-Y.; BOR-SHENG KO ; Yao M.; Shun C.-T.; Yen M.-L.; Lee M.-C.; Chen Y.-C.Stem Cells382319
972005Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: Implication for stem cell trackingHuang D.-M.; Hung Y.; BOR-SHENG KO ; Hsu S.-C.; Chen W.-H.; Chien C.-L.; Tsai C.-P.; Kuo C.-T.; Kang J.-C.; Yang C.-S.; Mou C.-Y.; Chen Y.-C.FASEB Journal267260
982005Gastrointestinal: Burkitt's lymphomaLiou J.-M.; Wang H.-P.; BOR-SHENG KO ; Cheng T.-Y.; Wu M.-S.; Lin J.-T.Journal of Gastroenterology and Hepatology (Australia)68
992002Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in TaiwanBOR-SHENG KO ; Tang J.-L.; Lee F.-Y.; Liu M.-C.; Tsai W.; Chen Y.-C.; Wang C.-H.; Sheng M.-C.; Lin D.-T.; Lin K.-H.; Tien H.-F.American Journal of Hematology2424
1002001Philadelphia chromosome-positive acute lymphoblastic leukemia in TaiwanBOR-SHENG KO ; Tang J.-L.; Tsai W.; Chen Y.-C.; Wang C.-H.; Sheng M.-C.; Lin D.-T.; Lin K.-H.; Tien H.-F.Annals of Hematology1010
1011999Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - The occurrence of retinoic acid syndrome is a risk factorBOR-SHENG KO ; Tang J.-L.; Chen Y.-C.; Yao M.; Wang C.-H.; Shen M.-C.; Tien H.-F.Leukemia7060